Details of the Drug Reposition

General Information of This Drug (ID: DMAAB9A)

Drug Name
Methylselenocysteine   DMAAB9A
Synonyms
Se-methylselenocysteine; 26046-90-2; (R)-2-Amino-3-(methylselanyl)propanoic acid; 3-(Methylseleno)-L-alanine; Se-Methyl-L-selenocysteine; L-Alanine, 3-(methylseleno)-; Selenium-methylselenocystine; Se-Methyl-seleno-L-cysteine; UNII-TWK220499Z; CHEBI:27812; TWK220499Z; Se-methylseleno-L-cysteine; Se-(Methyl)selenocysteine hydrochloride; (2R)-2-amino-3-methylselanylpropanoic acid; Se-methylseleno-L-cysteine, 98%; Selenomethylselenocysteine; CCRIS 5465; Selenomethyl selenocysteine; Methylseleno-L-cysteine; L-Se-methylselenocysteine; C4H9NO2Se; L-methylselenocysteine; methyl-L-selenocysteine; Cysteine, seleno-methyl-; Lopac0_000799; 3-(Methylselanyl)-L-alanine; CHEMBL62382; SCHEMBL420015; Se-(Methyl)seleno-L-cysteine; L-Selenomethylcysteine 0.5% Tr; 2218AB; ANW-64816; MFCD00800565; AKOS016005152; 2-Amino-3-methylselenyl propionic acid; CCG-204883; DB12697; SDCCGSBI-0050776.P002; NCGC00162258-01; NCGC00162258-02; HY-114245; CS-0080570; (2R)-2-amino-3-(methylselanyl)propanoic acid; C05689; J-016235; Q21099600
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Clinical Trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Clinical Trial [1]
Prostate cancer DISF190Y 2C82.0 Clinical Trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01611038) Methylselenocysteine Effects on Circadian Rhythm. U.S. National Institutes of Health.